JPS51136694A - Novel antiibacterial compound - Google Patents

Novel antiibacterial compound

Info

Publication number
JPS51136694A
JPS51136694A JP51051226A JP5122676A JPS51136694A JP S51136694 A JPS51136694 A JP S51136694A JP 51051226 A JP51051226 A JP 51051226A JP 5122676 A JP5122676 A JP 5122676A JP S51136694 A JPS51136694 A JP S51136694A
Authority
JP
Japan
Prior art keywords
antiibacterial
novel
compound
novel antiibacterial
antiibacterial compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP51051226A
Other languages
English (en)
Japanese (ja)
Inventor
Jierarudo Guriison Jiyon
Jiyooji Hooruden Kenesu
Furanshisu Hafuman Uiriamu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline LLC
Original Assignee
SmithKline Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Corp filed Critical SmithKline Corp
Publication of JPS51136694A publication Critical patent/JPS51136694A/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/36One oxygen atom
    • C07D263/38One oxygen atom attached in position 2
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP51051226A 1975-05-05 1976-05-04 Novel antiibacterial compound Pending JPS51136694A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57422575A 1975-05-05 1975-05-05
US62668675A 1975-10-29 1975-10-29

Publications (1)

Publication Number Publication Date
JPS51136694A true JPS51136694A (en) 1976-11-26

Family

ID=27076332

Family Applications (1)

Application Number Title Priority Date Filing Date
JP51051226A Pending JPS51136694A (en) 1975-05-05 1976-05-04 Novel antiibacterial compound

Country Status (11)

Country Link
JP (1) JPS51136694A (enrdf_load_stackoverflow)
AU (1) AU500636B2 (enrdf_load_stackoverflow)
CH (3) CH623331A5 (enrdf_load_stackoverflow)
DE (1) DE2619458A1 (enrdf_load_stackoverflow)
DK (1) DK194776A (enrdf_load_stackoverflow)
ES (3) ES447577A1 (enrdf_load_stackoverflow)
FR (2) FR2324639A1 (enrdf_load_stackoverflow)
GB (2) GB1553429A (enrdf_load_stackoverflow)
IE (1) IE43845B1 (enrdf_load_stackoverflow)
LU (1) LU74873A1 (enrdf_load_stackoverflow)
NL (1) NL7604797A (enrdf_load_stackoverflow)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6036458A (ja) * 1983-08-08 1985-02-25 Sumitomo Chem Co Ltd β−ラクタム誘導体の製造法

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4122086A (en) * 1977-07-26 1978-10-24 Smithkline Corporation Isopenicillins
FR2505840A1 (fr) * 1981-05-13 1982-11-19 Roussel Uclaf Nouveaux produits derives de l'acide 2-amino thiazolyl 2-oxyimino acetamido bicyclo-octene carboxylique, leur procede de preparation et leur application comme medicaments
FR2552089B2 (fr) * 1981-05-13 1985-10-25 Roussel Uclaf Nouveaux produits derives de l'acide 2-amino thiazolyl 2-oxyimino acetamido bicyclo-octene carboxylique, leur procede de preparation et leur application comme medicaments
CA1262128A (en) * 1981-08-27 1989-10-03 Christian N. Hubschwerlen .beta.-lactams
FR2538389B2 (fr) * 1981-10-23 1986-05-16 Roussel Uclaf Nouveaux produits derives de l'acide 3-amino 2-oxo azetidine-1-sulfamique, nouveau procede de preparation de produits optiquement actifs, application des nouveaux produits comme medicaments et produits necessaires a leur preparation
FR2558467B2 (fr) * 1981-10-23 1987-03-20 Roussel Uclaf Nouveau produit derive de l'acide 3-amino 2-oxo azetidine 1-sulfamique, son procede de preparation, son application comme medicament et un produit intermediaire necessaire a sa preparation
FR2515182B1 (fr) * 1981-10-23 1986-05-09 Roussel Uclaf Nouveaux produits derives de l'acide 3-amino 2-oxo azetidine 1-sulfamique, leur procede de preparation, leur application comme medicaments et les produits intermediaires necessaires a leur preparation
FR2559486B1 (fr) * 1984-02-13 1988-02-12 Roussel Uclaf Nouveaux derives de l'acide 1-dethia 2-thia cephalosporanique, leur procede de preparation et leur application comme medicaments
FR2586020B2 (fr) * 1985-08-09 1988-10-14 Roussel Uclaf Nouveaux derives de l'acide 1-dethia 2-thia cephalosporanique, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les contenant
FR2588867B1 (fr) * 1985-10-23 1988-12-09 Roussel Uclaf Nouveaux produits derives de la serie de la 3-amino 2-oxo azetidine, leur procede de preparation et leur application
FR2610630B2 (fr) * 1987-02-06 1989-05-26 Roussel Uclaf Nouveaux derives de l'acide 1-dethia 2-thia cephalosporanique, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les contenant

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2046823A1 (de) * 1970-09-23 1972-03-30 Farbwerke Hoechst AG vormals Meister Lucius & Brüning, 6000 Frankfurt Neue Azetidinone-(2) und Verfahren zu deren Herstellung

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6036458A (ja) * 1983-08-08 1985-02-25 Sumitomo Chem Co Ltd β−ラクタム誘導体の製造法

Also Published As

Publication number Publication date
ES447577A1 (es) 1977-12-01
NL7604797A (nl) 1976-11-09
GB1553430A (en) 1979-09-26
IE43845B1 (en) 1981-06-17
AU500636B2 (en) 1979-05-31
ES460722A1 (es) 1978-05-01
IE43845L (en) 1976-11-05
FR2324639A1 (fr) 1977-04-15
DE2619458A1 (de) 1976-11-18
CH624670A5 (en) 1981-08-14
AU1366976A (en) 1977-11-10
FR2313362B1 (enrdf_load_stackoverflow) 1979-03-23
ES460746A1 (es) 1978-10-01
CH623331A5 (en) 1981-05-29
GB1553429A (en) 1979-09-26
LU74873A1 (enrdf_load_stackoverflow) 1977-01-12
FR2313362A1 (fr) 1976-12-31
CH627475A5 (en) 1982-01-15
DK194776A (da) 1976-11-06
FR2324639B1 (enrdf_load_stackoverflow) 1978-11-03

Similar Documents

Publication Publication Date Title
GB1539006A (en) Aminoalkylammonium compound
JPS57112389A (en) 1-sulfonylbenzimidazole compound
JPS51113900A (en) Riphamycin compound
PT65688A (en) Novel 1-benzazolylalkyl-4-substituted-piperidines
JPS5589278A (en) Novel dibenzopyrans
JPS5273891A (en) Novel cephalospoline compound
JPS5223076A (en) Antiiinflammatory compound
JPS51136694A (en) Novel antiibacterial compound
ZA764267B (en) Sulphine compounds
GB1557482A (en) Substituted tetranorprostaglandins
PH16245A (en) Novel 3-acyloxymethyl-cephem compounds
PH12497A (en) Novel n-aryl-n-(1-l-piperidinyl)-arylacetamides
JPS51143699A (en) Riphamycin compound
JPS5236665A (en) 44dithioo33imide azethizinee 22one compound
JPS51115450A (en) Phosphorrcontaining compounds
JPS56142292A (en) Novel compound
JPS5231062A (en) Perfluoroalkylthionorbornane compound
JPS5231095A (en) Cephlosporin type compound
JPS5278869A (en) Thienylpolyene compound
JPS5285106A (en) Carbamateesulphenyllcarbamoylfluoride compounds
ZM576A1 (en) Compounds
GB1518029A (en) Substituted aminoalkylaminopyridine compounds
ZA765684B (en) Novel n-aryl-n-(1-l-4-piperidinyl)-arylacetamides
JPS5219667A (en) Novel sulpheneamide compound
JPS5271454A (en) Compound